United States· US:73684-300_4694618d-6999-29b1-e063-6394a90ab004

Corphena

A dexchlorpheniramine product containing dexchlorpheniramine maleate, registered in United States by BluCrest Pharmaceuticals LLC. The same ATC class is registered in 5 of our 19 countries.

ATC R06AB02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCorphenaATCR06AB02REGISTER NO.US:73684-300_4694618d…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Dexchlorpheniramine is registered in 5 of 19 countries.

Countries holding a registration under ATC R06AB02 (dexchlorpheniramine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Dexchlorpheniramine · ATC R06AB02

5 / 19 countries

  • Finlandprice
  • Franceprice
  • Netherlands
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DEXCHLORPHENIRAMINE MALEATE
Manufacturer
BluCrest Pharmaceuticals LLC
Country
United States (US)
ATC code
R06AB02
ATC class
Dexchlorpheniramine
Defined daily dose
6 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    73684-300-08
  • ndc11
    7368430008
    237 mL in 1 BOTTLE, PLASTIC (73684-300-08)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dexchlorpheniramine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexchlorpheniramine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Spain · Dexclorfeniramina Maleato Accord, Polaramine
  • France · Polaramine
  • Italy · Polaramin
  • Netherlands · Polaramine
  • Norway · Aniramin, Dexchlorpheniramine Maleate Accord
  • Portugal · Dexclorofeniramina Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1e7bf92-941a-413e-9aa7-6fb5a93a3f25
GET /v1/drugs/f1e7bf92-941a-413e-9aa7-6fb5a93a3f25?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2",
  "substance": "DEXCHLORPHENIRAMINE MALEATE",
  "productndc": "73684-300",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/5mL",
  "application_number": "ANDA202520",
  "marketing_category": "ANDA"
}

See everything about dexchlorpheniramine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.